190
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Dose-Response Effect of Arabinoxylooligosaccharides on Gastrointestinal Motility and on Colonic Bacterial Metabolism in Healthy Volunteers

, MS, , PhD, , PhD, , PhD, , PhD, , PhD, , MD, PhD & , PhD show all
Pages 512-518 | Received 27 Jul 2007, Accepted 25 Apr 2008, Published online: 14 Jun 2013
 

Abstract

Objective: Arabinoxylooligosaccharides (AXOS) are non-digestible in the upper gastrointestinal tract and have been shown to exert prebiotic effects in animals. The aim of this study was to characterize the influence of AXOS with an average degree of polymerization of 15 and an average degree of arabinose substitution of 0.26 (AXOS-15-0.26) on gastrointestinal motility and colonic bacterial metabolism in healthy human volunteers.

Methods: Twelve healthy volunteers received five test meals, containing different amounts of AXOS-15-0.26, with one week intervals between each test meal. Breath tests were used to measure gastric emptying rate, oro-cecal transit time (OCTT) and hydrogen excretion. Colonic bacterial metabolism was estimated using the biomarkers lactose-[15N, 15N′]-ureide (15N-LU) and p-cresol.

Results: Gastric emptying and OCTT were not influenced by addition of varying amounts of AXOS-15-0.26. Administration of 2.2g or 4.9g AXOS-15-0.26 significantly decreased the urinary 15N-excretion (respectively p = 0.008 and p = 0.035) as compared to the baseline, whereas fecal 15N-excretion was significantly increased (respectively p = 0.034 and p = 0.019). This shift from urinary to fecal 15N-excretion suggests a higher uptake or incorporation by bacteria due to the stimulation of colonic bacterial growth and/or metabolic activity. Furthermore, a significant increase in hydrogen excretion after administration of 2.2g (p = 0.002) and 4.9g (p = 0.004) AXOS-15-0.26 was observed. No influence on urinary p-cresol excretion was observed.

Conclusion: These findings suggest that a minimal dose of 2.2g AXOS-15-0.26 favorably modulates the colonic bacterial metabolism in healthy humans. However, long term studies are required to confirm a possible prebiotic effect.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.